Primary Endpoint Successfully Achieved in Mesoblast’s Phase 3 Cell Therapy Trial for Acute Graft Versus Host Disease Genetics Investing
G1 Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Operational Highlights Genetics Investing
Affimed Announces Closing of Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares Genetics Investing
Photocure Announces U.S. FDA Approval of New Indications for Blue Light Cystoscopy Pharmaceutical Investing
Agios Receives FDA Priority Review for New Drug Application: How are Gene Therapy Drug Approvals Impacting Stocks? Genetics Investing
JAMA Oncology Publication Demonstrates EndoPredict Significantly Outperforms Oncotype DX Genetics Investing
Argos Announces Issuance of Patent Covering the Foundation for Manufacturing its HIV Immunotherapy Genetics Investing
Kura Oncology Provides Update on Phase 2 Trial of Tipifarnib in HRAS Mutant Head and Neck Cancer Biotech Investing